Niacinamide
Hyperphosphatemia
Phosphorus
Nicotinamide decreases MHC class II but not MHC class I expression and increases intercellular adhesion molecule-1 structures in non-obese diabetic mouse pancreas. (1/1693)
Pancreases of untreated and nicotinamide (NIC)-treated pre-diabetic (10-week-old) and overtly diabetic (25-week-old) female NOD (non-obese diabetic) mice and of NON (non-obese non-diabetic) control mice were studied, with the following results. (1) Islets and ducts of overtly diabetic untreated NOD mice (25-week-old) were found to express low levels of MHC class I and II molecules, like NON controls, and high levels of adhesive molecules. (2) NIC was able to slightly affect glycaemia and insulitis, slowing down diabetes progression. Moreover it significantly decreased MHC class II expression (but not class I) in vivo by week 10, and significantly enhanced intercellular adhesion molecule-1 (ICAM-1) expression, mainly by week 25, within the pancreas, where 5-bromo-2'-deoxyuridine positive nuclei and insulin positive cells were present, demonstrating that a stimulation of endocrine cell proliferation occurs. (3) In addition, NIC partly counteracted the fall of superoxide dismutase levels, observed in untreated diabetic NOD animals. (4) In vitro studies demonstrated that NIC: (i) was able to significantly reduce nitrite accumulation and to increase NAD+NADH content significantly, and (ii) was able to increase the levels of interleukin-4, a T helper 2 lymphocyte (Th2) protective cytokine, and of interferon-alpha (IFN-alpha), which is known to be able to induce MHC class I and ICAM-1 but not MHC class II expression, as well as IFN-gamma, which is also known to be able to induce MHC class I and ICAM-1 expression. The latter, although known to be a proinflammatory Th1 cytokine, has also recently been found to exert an anti-diabetogenic role. This study therefore clearly shows that adhesive mechanisms are ongoing during the later periods of diabetes in pancreatic ducts of NOD mice, and suggests they may be involved in a persistence of the immune mechanisms of recognition, adhesion and cytolysis and/or endocrine regeneration or differentiation processes, as both NIC-increased ICAM-1 expression and 5-bromo-2'-deoxyuridine positivity imply. The effects of NIC on MHC class II (i.e. a reduction) but not class I, and, mainly, on ICAM-1 expression (i.e. an increase), together with the increase in Th2 protective cytokine levels are very interesting, and could help to explain its mechanism of action and the reasons for alternate success or failure in protecting against type 1 diabetes development. (+info)Observations on the use of tetracycline and niacinamide as antipruritic agents in atopic dogs. (2/1693)
Tetracycline and niacinamide were administered in combination to 19 atopic dogs to determine their effectiveness in controlling pruritus. The pruritus was controlled successfully in only one dog. One dog experienced diarrhea that was severe enough to warrant stopping the medication. (+info)Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress. (3/1693)
OBJECTIVE: Inhibitors of poly (ADP-ribose) synthetase (PARS) activity reduce the infarct size caused by regional myocardial ischaemia and reperfusion in the rabbit and rat in vivo. The mechanism of action of these inhibitors is unclear. Here we investigate the effects of the PARS inhibitor 3-aminobenzamide (3-AB) on infarct size caused by ischaemia and reperfusion of the isolated, perfused heart of the rat. We also investigate the role of PARS in the hydrogen peroxide-mediated cell injury/necrosis in rat cardiac myoblasts. METHODS: Rat isolated hearts perfused at constant pressure (80 mmHg) were subjected to 35 min of regional ischaemia and 2 h of reperfusion. Infarct size was determined at the end of the experiment using nitro-blue tetrazolium. 3-AB (300 microM) or 3-aminobenzoic acid (3-ABA, 300 microM) were infused during the reperfusion period. Rat cardiac myoblasts (H9c2 cells) were preincubated with the PARS inhibitors, 3-AB. nicotinamide (Nic) or 1,5-dihydroxyisoquinoline (ISO) or the inactive analogues 3-ABA or nicotinic acid (NicA) prior to exposure with hydrogen peroxide (1 mM). Cell injury was assessed by measuring mitochondrial respiration and cell necrosis by measuring the release of LDH. PARS activity was determined by measuring the incorporation of NAD into nuclear proteins. RESULTS: Regional ischaemia and reperfusion of the isolated rat heart resulted in an infarct size of 54% which was reduced by 3-AB, but not by 3-ABA. Exposure of rat cardiac myoblasts to hydrogen peroxide caused an increase in PARS activity and cell injury/necrosis which was attenuated by pretreatment with the PARS inhibitors. CONCLUSION: Inhibition of the activity of PARS attenuates the cell death associated with oxidant stress in rat cardiac myoblasts and heart. (+info)Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine. (4/1693)
BACKGROUND: We recently reported that the administration of niceritorol (a nicotinic acid derivative which improves lipid metabolism and peripheral circulation, and is used for the treatment of hyperlipidaemia and impaired peripheral circulation) to patients with hyperphosphataemia undergoing dialysis decreased the serum phosphate (Pi) concentration. We found that this was due to an acceleration of faecal Pi excretion by niceritrol. METHODS: Intestinal brush border membrane vesicles (BBMVs) were prepared from rat jejunum, and the Na+-dependent and Na+-independent Pi transport activities in these vesicles were measured. In addition, the functional Pi transporter from rat small intestine was injected in Xenopus oocytes, and the effect of nicotinamide on the levels of its expression were measured by northern blotting. RESULTS: The Na+-dependent component was significantly decreased in the BBMVs isolated from rats treated with nicotinamide, while the Na+-independent component was not changed. Kinetic studies demonstrated that the decreased activity was due to reduction of the Vmax value and not an elevation of the Km values. When poly(A)+RNA from rats treated with nicotinamide was microinjected into Xenopus oocytes, the Pi transport activity was significantly decreased compared with that in the control animals. In addition, there were no significant changes in Na/Pi cotransporters and activators, but the vitamin D receptor mRNA level was reduced to 80% of the control level. CONCLUSIONS: These observations suggest that nicotinamide may regulate the expression of a major functional Na/Pi cotransporter in the rat small intestine. (+info)Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis. (5/1693)
Apoptosis was induced by treating L1210 leukaemia cells with mechlorethamine, and SW620 colorectal cells with doxorubicin. The onset and progression of apoptosis were monitored by assessing caspase activation, mitochondrial transmembrane potential, phosphatidylserine externalization, DNA fragmentation and cell morphology. In parallel, 31P magnetic resonance (MR) spectra of cell extracts were recorded. In L1210 cells, caspase activation was detected at 4 h. By 3 h, the MR spectra showed a steady decrease in NTP and NAD, and a significant build-up of fructose 1,6-bisphosphate (F-1,6-P) dihydroxyacetonephosphate and glycerol-3-phosphate, indicating modulation of glycolysis. Treatment with iodoacetate also induced a build-up of F-1,6-P, while preincubation with two poly(ADP-ribose) polymerase inhibitors, 3-aminobenzamide and nicotinamide, prevented the drop in NAD and the build-up of glycolytic intermediates. This suggested that our results were due to inhibition of glyceraldehyde-3-phosphate dehydrogenase, possibly as a consequence of NAD depletion following poly(ADP-ribose) polymerase activation. Doxorubicin treatment of the adherent SW620 cells caused cells committed to apoptosis to detach. F-1,6-P was observed in detached cells, but not in treated cells that remained attached. This indicated that our observations were not cell line- or treatment-specific, but were correlated with the appearance of apoptotic cells following drug treatment. The 31P MR spectrum of tumours responding to chemotherapy could be modulated by similar effects. (+info)Neuroprotective effects of poly (ADP-ribose) polymerase inhibitors in transient focal cerebral ischemia of rats. (6/1693)
AIM: To explore the role of poly (ADP-ribose) polymerase (PARP) in focal cerebral ischemia with reperfusion injury. METHODS: Male Wistar rats underwent 3.5-h of temporary middle cerebral artery occlusion by intraluminal suture. Infarction volume was showed with 2,3,5-triphenyltetrazolium chloride (TTC) staining and quantitated by image analysis system, neurologic scores were determined with a 0-5 grading scale. RESULTS: 3-Aminobenzamide (3-AB) 10 mg.kg-1 or nicotinamide (Nic) at 20 mg.kg-1 showed potent neuroprotective effects within 0-6 h, neurologic deficits were attenuated. With the increasing dose of PARP inhibitors, beneficial effects were compromised, particularly, administration of Nic 60 mg.kg-1 at the onset of reperfusion drastically accelerated brain damage. Phytomenadione, a selective inhibitor of mono (ADP-ribosyl) transferase, had little effect on infarction volume. CONCLUSION: Transient incomplete inhibition of PARP provides a neuroprotective effects against cerebral ischemia-reperfusion injury, with a relatively wide therapeutic window, whereas severe inhibition of this enzyme, especially in reperfusion phase, is detrimental. (+info)Inhibitors of poly (ADP-ribose) synthetase protect rat proximal tubular cells against oxidant stress. (7/1693)
BACKGROUND: The generation of reactive oxygen species (ROS) has been implicated in the pathogenesis of renal ischemia-reperfusion injury. ROS produce DNA strand breaks that lead to the activation of the DNA-repair enzyme poly (ADP-ribose) synthetase (PARS). Excessive PARS activation results in the depletion of its substrate, nicotinamide adenine dinucleotide (NAD) and subsequently of adenosine 5'-triphosphate (ATP), leading to cellular dysfunction and eventual cell death. The aim of this study was to investigate the effect of various PARS inhibitors on the cellular injury and death of rat renal proximal tubular (PT) cells exposed to hydrogen peroxide (H2O2). METHODS: Rat PT cell cultures were incubated with H2O2 (1 mM) either in the presence or absence of the PARS inhibitors 3-aminobenzamide (3-AB, 3 mM), 1,5-dihydroxyisoquinoline (0.3 mM) or nicotinamide (Nic, 3 mM), or increasing concentrations of desferrioxamine (0.03 to 3 mM) or catalase (0.03 to 3 U/ml). Cellular injury and death were determined using the MTT and lactate dehydrogenase (LDH) assays, respectively. H2O2-mediated PARS activation in rat PT cells and the effects of PARS inhibitors on PARS activity were determined by measurement of the incorporation of [3H]NAD into nuclear proteins. RESULTS: Incubation of rat PT cells with H2O2 significantly inhibited mitochondrial respiration and increased LDH release, respectively. Both desferrioxamine and catalase reduced H2O2-mediated cellular injury and death. All three PARS inhibitors significantly attenuated the H2O2-mediated decrease in mitochondrial respiration and the increase in LDH release. Incubation with H2O2 produced a significant increase in PARS activity that was significantly reduced by all PARS inhibitors. 3-Aminobenzoic acid (3 mM) and nicotinic acid (3 mM), structural analogs of 3-AB and Nic, respectively, which did not inhibit PARS activity, did not reduce the H2O2-mediated injury and necrosis in cultures of rat PT cells. CONCLUSION: We propose that PARS activation contributes to ROS-mediated injury of rat PT cells and, therefore, to the cellular injury and cell death associated with conditions of oxidant stress in the kidney. (+info)Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933. (8/1693)
PURPOSE: A three-step phase I/II trial associating accelerated radiotherapy with carbogen (step 1, ARCO), with nicotinamide (step 2, ARN), or with both (step 3, ARCON) was conducted, the aim of which was to overcome the effects of proliferation and hypoxia as potential causes of tumor radioresistance in glioblastoma multiforme. PATIENTS AND METHODS: Radiotherapy consisted of 60 Gy delivered over 4 weeks in 1.5-Gy fractions twice daily, 5 days a week. Carbogen breathing was started 5 minutes before each fraction and continued until the end of each treatment session. Nicotinamide was given daily as a single oral dose of 85 mg/kg. RESULTS: A total of 115 patients with a median age of 55 years were registered. Of 107 eligible patients, 23 were registered in step 1, 28 in step 2, and 56 in step 3. The planned treatment was administered without any interruption in 72% of patients (86% in ARCO but 68% in ARN and ARCON). The incidence and severity of acute skin and mucous membrane toxicity were higher in patients who received nicotinamide (ie, the ARN and ARCON groups). Grade 1 to 2 gastrointestinal toxicity was observed in 44% of patients in the ARN group and 32% of patients in the ARCON group, but only in 8% of patients in the ARCO group. Eight percent of evaluated patients presented with abnormal liver test results at treatment completion. The dose of corticosteroids had to be increased in 44% of patients. Late neurologic side effects were similar in all treatment steps and were observed mostly in patients with disease progression. Median survival times for patients treated with ARCO, ARN, and ARCON were 10.1, 9.7, and 11.1 months, respectively. CONCLUSION: Feasibility of ARCO treatment was good but that of ARN and ARCON was only fair. This probably reflected the higher acute toxicity rate, particularly gastrointestinal, for patients receiving nicotinamide. The dose of corticosteroids had to be increased frequently during treatment, suggesting a higher than expected acute neurologic toxicity. Overall survival was similar in the three treatment steps and not different when compared with results of other series that used radiotherapy alone. (+info)Niacinamide, also known as vitamin B3, is a water-soluble vitamin that plays a crucial role in various bodily functions. In the medical field, niacinamide is used as a dietary supplement and medication to treat a variety of conditions, including: 1. Hyperpigmentation: Niacinamide is used to treat hyperpigmentation, which is the darkening of the skin caused by exposure to the sun or other factors. It works by inhibiting the production of melanin, the pigment that gives skin its color. 2. Rosacea: Niacinamide is used to treat rosacea, a chronic skin condition characterized by redness, flushing, and bumps on the face. It helps to reduce inflammation and improve the skin's barrier function. 3. Acne: Niacinamide is used to treat acne by regulating oil production, reducing inflammation, and improving the skin's barrier function. 4. Dermatitis: Niacinamide is used to treat dermatitis, a skin condition characterized by redness, itching, and inflammation. It helps to reduce inflammation and improve the skin's barrier function. 5. Aging skin: Niacinamide is used to treat aging skin by improving skin elasticity, reducing fine lines and wrinkles, and improving skin texture. Niacinamide is generally considered safe when taken in recommended doses. However, it can cause side effects such as flushing, itching, and stinging when applied topically. It is important to consult a healthcare professional before taking niacinamide as a supplement or medication.
Hyperphosphatemia is a medical condition characterized by an abnormally high level of phosphate ions (PO43-) in the blood. The normal range of serum phosphate levels in adults is typically between 2.5 and 4.5 millimoles per liter (mmol/L). Hyperphosphatemia can be caused by a variety of factors, including kidney disease, excessive intake of phosphorus-rich foods or supplements, certain medications, and genetic disorders. It can also be a complication of other medical conditions, such as hyperparathyroidism, vitamin D deficiency, and bone disorders. Symptoms of hyperphosphatemia may include muscle weakness, bone pain, and kidney problems. In severe cases, it can lead to complications such as kidney failure, bone disease, and heart problems. Treatment for hyperphosphatemia depends on the underlying cause and may include dietary changes, medications to lower phosphate levels, and in severe cases, dialysis or kidney transplantation.
Phosphorus is a chemical element with the symbol P and atomic number 15. It is an essential nutrient for living organisms and is found in all cells of the body. In the medical field, phosphorus is often used as a diagnostic tool to measure the levels of phosphorus in the blood, which can be an indicator of various medical conditions. High levels of phosphorus in the blood can be caused by kidney disease, certain medications, or excessive intake of phosphorus-rich foods. Low levels of phosphorus can be caused by malnutrition, certain medications, or excessive loss of phosphorus through the urine. Phosphorus is also used in the treatment of certain medical conditions, such as osteoporosis, where it is used to help build strong bones. It is also used in the treatment of certain types of cancer, such as multiple myeloma, where it is used to help slow the growth of cancer cells. In addition to its use in medicine, phosphorus is also used in the production of fertilizers, detergents, and other industrial products.
Nicotinamide
Vitamin B3
Niacin
Nicotinyl methylamide
Hyperpigmentation
Megavitamin therapy
GABAA receptor
Pemphigoid
Tumor hypoxia
Dermatitis herpetiformis
1-Methylnicotinamide
Hartnup disease
Natural skin care
Vitamin
Olay
Pasta
Fine chemical
Quisp
Orthomolecular medicine
Canine discoid lupus erythematosus
Glow & Lovely
Rhodococcus rhodochrous
Telogen effluvium
Hyram Yarbro
Honeycomb (cereal)
Coca-Cola
List of MeSH codes (D03)
Ham's tissue culture medium
Bodyarmor SuperDrink
Tab Energy
Niacinamide: MedlinePlus Supplements
B3 Nice 10% Niacinamide serum - Sunday Riley | Sephora
NIP+FAB X ASOS Exclusive Niacinamide Primer Essence | ASOS
Niacinamide Skincare | Skincare Ingredients | LloydsPharmacy
La Roche-Posay Niacinamide B10 Serum 30ml | Boots
Paula's Choice CLINICAL Niacinamide 20% Treatment (0.67 fl. oz.) Reviews
- Dermstore
Glow Recipe Watermelon Glow Niacinamide Dew Drops - Popdust
Niacinamide & Vitamin C: Can You Layer Them Together? | mindbodygreen
Buy Niacinamide, 500 mg 100ct from Natures Life and Save Big at Vitanetonline.com
Niacinamide 90 Caps , made by pure-encapsulation
IT Cosmetics Medium CC+ Nude Glow Lightweight Foundation + Glow Serum with SPF 40 and Niacinamide Review & Swatches
eFeedLink - Increased competition in China's niacinamide market
Minimalist 10% Niacinamide Face Serum with Zinc Price, Offers in India + Cashback | 2023
Vitamin C and Niacinamide Brightening Bundle
- Shearadiance
Niacinamide - Yudoyu
Niacinamide | Phoenix Villefun
Niacinamide Solution - TAHNYC
Niacinamide - Simple Organic
Niacinamide Serum - Naturium
What is Niacinamide?
- NAYA
Dragonfruit + Niacinamide Exfoliator
- purlisse
niacinamide concentrate | skoah - skoahUS
Niacinamide - Doctor E's Choice Store
Niacinamide 10% Cream | STUDIO MMK
Niacinamide | Ghost Democracy | Positive Ingredients
Niacinamide 500
| Health Center Store
Niacinamide 10% + Zinc 1% - SkinToday
NIACINAMIDE RESTORATIVE NIGHT GEL
- Noiant
PRO Strength Niacinamide 30ml
- Skinsmiths
Serum11
- PURE NIACINAMIDE 10 SERUM: Our first 10% Niacinamide concentrate. (boots.com)
- Melanin blocker: 10% niacinamide, PHE Resorcinol Anti-inflammatory: 10% niacinamide Exfoliating: 5% HEPES Pure Niacinamide 10 Serum efficacy has been demonstrated via a clinical study carried out on 41 subjects - Tested under dermatological control on sensitive skin. (boots.com)
- Harnessing the power of niacinamide and zinc this potent serum is perfect for combatting blemishes, enlarged pores and uneven skin tone. (skintoday.co)
- Our Niacinamide 10% + Zinc 1% formula is a water-based serum that boosts skin brightness, improves skin smoothness and reinforces the skin barrier over time. (theordinary.com)
- Discover the benefits of the supercharged skincare ingredient, niacinamide, found in the result-driven formula of Charlotte's Magic Serum Crystal Elixir. (charlottetilbury.com)
- Niacinamide has several fantastic benefits for your skin's health and can be found at a concentration of 5% in the EXPERTLY-BLENDED formula of Charlotte's GROUND-BREAKING, SCIENCE-POWERED skincare innovation, Charlotte's Magic Serum Crystal Elixir . (charlottetilbury.com)
- Charlotte's Magic Serum Crystal Elixir contains a 5% concentration of NIACINAMIDE, otherwise known as Vitamin B3, which is is essential for skin health in many ways - it works as an anti-oxidant, but in addition to this it can improve the appearance of pores for a complexion which looks smoother and more even. (charlottetilbury.com)
- Normally you need to use laser treatment or micro-needling to address this concern, but for a less invasive approach, I can now recommend Charlotte's Magic Serum Crystal Elixir which contains a 5% concentration of Niacinamide that works hard to help minimise the appearance of your pores. (charlottetilbury.com)
- Made with quality ingredients, our Vitamin B3 Niacinamide skin serum doesn't have room for alcohol or parabens! (somvranto.com)
- That's why your Niacinamide serum comes with easy instructions: - Wash and dry your face. (somvranto.com)
- Harnessing the (anything but ordinary) power of niacinamide and zinc - with a surprisingly small price tag - this potent serum is perfect for combatting blemishes, enlarged pores and uneven skin tone. (londonstore.lk)
Pure Niacinamide2
- A high-strength vitamin and mineral blemish formula with 10 percent pure niacinamide and one percent zinc PCA. (go4shine.pk)
- Pure Niacinamide 10% evens skin tone, repairs and brightens. (drlauraclinic.ie)
Ingredients3
- Featuring high concentrations of two of the most efficacious blemish-battling ingredients out there (niacinamide and zinc), this swiftly soothes skin and improves its overall health. (skintoday.co)
- You'll most often find this form of vitamin B listed in skincare ingredients as niacinamide or nicotinic acid. (biossance.com)
- This Niacinamide Brightening Toner is formulated with a soothing blend of brightening ingredients that work to reduce the appearance of dullness, uneven skin tone, and enlarged pores. (beautysquareke.com)
Vitamin11
- Niacinamide, also called nicotinamide, is a form of vitamin B3. (medlineplus.gov)
- People use niacinamide to prevent vitamin B3 deficiency and related conditions such as pellagra. (medlineplus.gov)
- Niacinamide is a flush-free form of Vitamin B-3 intended to provide nutritive support for the healthy metabolism of carbohydrates, protein and fat. (vitanetonline.com)
- Niacinamide 5% - Niacinamide is the bioactive form of Vitamin B3. (skinsmiths.com)
- Activated by Niacinamide (Vitamin B3) and Vitamin B5 to strengthen healthy skin barrier function for a refined and more even complexion. (skinsmiths.com)
- It contains a high 10% concentration of Niacinamide (vitamin b3) and zinc PCA. (theordinary.com)
- Niacinamide is a specific, water-soluble form of vitamin B3. (biossance.com)
- When niacinamide is applied to skin, it's broken down into the form of vitamin B that our skin cells can use, the coenzyme nicotinamide adenine dinucleotide. (biossance.com)
- Niacinamide is a MULTI-ACTION, SUPERCHARGED version of Vitamin B3. (charlottetilbury.com)
- A Powerful Vitamin C, MSM, and Niacinamide formula that provides an even skin tone appearance against visible signs of aging, environmental stress, and damage as well as general skin-brightening activity for photodamaged skin. (facenearth.com)
- Niacinamide (vitamin B3) reduces the appearance of skin blemishes and congestion. (go4shine.pk)
Niacin2
- Niacin is converted to niacinamide when it is taken in amounts greater than what is needed by the body. (medlineplus.gov)
- Unlike niacin, niacinamide doesn't help treat high cholesterol. (medlineplus.gov)
Zinc3
- A must-have for battling breakouts, The Ordinary's Niacinamide 10% + Zinc 1% regulates sebum production to minimise pores and reduce blemish-causing bacteria, keeping your complexion clear, calm and collected. (skintoday.co)
- A superlative skin improver, niacinamide boosts the skin's immunity and improves moisture retention, while a brilliant shot of zinc PCA works to repair damaged skin and promote collagen production. (skintoday.co)
- Note: Niacinamide and Zinc PCA is not a treatment for acne. (theordinary.com)
Fine lines and wrinkles2
- Retinoid, Hexylresorcinol, and Niacinamide: A clinically backed blend that visibly reduces fine lines and wrinkles and diminishes the appearance of dark spots and hyperpigmentation while being gentle to skin. (sephora.com)
- This fast-absorbing treatment is formulated with a blend of a retinoid, hexylresorcinol, and niacinamide to visibly reduce fine lines and wrinkles and diminish the appearance of dark spots and hyperpigmentation. (sephora.com)
Skincare ingredient1
- Niacinamide is the skincare ingredient on every influencer's lips - and with good reason. (biossance.com)
Reduces1
- Niacinamide reduces inflammation, which may help ease redness from eczema, acne, and other inflammatory skin conditions. (vegantabs.com)
Redness1
- Niacinamide cream might cause mild burning, itching, or redness. (medlineplus.gov)
Potent1
- Our refreshing gel-cream is formulated with a potent level of niacinamide, helping to balance skin's hydration and reducing the appearance of pores, for healthier-looking and dewy skin. (secondskin.nz)
Acne2
- Applying a cream containing niacinamide seems to improve the appearance of skin in people with acne. (medlineplus.gov)
- Niacinamide may be helpful for severe acne, especially inflammatory forms like papules and pustules. (vegantabs.com)
Inflammation1
- At the cellular level, niacinamide acts as an antioxidant, fighting inflammation and free radical damage. (biossance.com)
Decrease2
- In people who need hemodialysis due to kidney failure and have high levels of phosphate, taking niacinamide by mouth seems to help decrease phosphate levels. (medlineplus.gov)
- Niacinamide might decrease how fast the body breaks down carbamazepine. (medlineplus.gov)
Pores1
- Two stand-out benefits of niacinamide are that it helps to improve the overall appearance of the skin tone and reduce the appearance of pores. (charlottetilbury.com)
Dark spots1
- Some research has found niacinamide concentrations can be helpful in lightening dark spots. (vegantabs.com)
Extract1
- The formula is enhanced with GentleBright Technology, combining niacinamide and sea daffodil extract to help improve the appearance of uneven tone and dullness. (lookfantastic.com)
Formula1
- A powerful dermatologically tested formula that contains 10% niacinamide, and 5% HEPES (gently exfoliates). (boots.com)
Helps5
- Niacinamide is also known to inhibit melanosome transfer resulting in a lightening effect that helps even skin tone. (skinsmiths.com)
- Niacinamide helps to lock in moisture and prevent transepidermal water loss, so it has a moisturizing function in addition to all its other benefits. (biossance.com)
- Niacinamide helps build keratin, a type of protein that keeps your skin firm and healthy. (vegantabs.com)
- Niacinamide can help your skin grow a ceramide (lipid) barrier, which can, in turn, helps retain moisture. (vegantabs.com)
- Niacinamide helps build cells in the skin while also protecting them from environmental stresses, such as sunlight, pollution, and toxins. (vegantabs.com)
Glow1
- Niacinamide can also be found in Charlotte's colour-correcting face primer, Brightening Youth Glow ! (charlottetilbury.com)
Products2
- Niacinamide prescription products are US FDA approved for preventing and treating pellagra. (medlineplus.gov)
- Prescription products containing niacinamide are safe when taken as directed. (medlineplus.gov)
Foods1
- Niacinamide-containing foods or supplements are safe when taken in doses lower than 35 mg daily. (medlineplus.gov)
Healthy2
- Niacinamide is required for the function of fats and sugars in the body and to maintain healthy cells. (medlineplus.gov)
- Niacinamide can concurrently rebuild healthy skin cells while also protecting them from damage caused by ultraviolet rays. (vegantabs.com)
Body1
- Your body can't produce niacinamide on its own. (biossance.com)
Clear1
- Niacinamide is one of the most effective natural treatments for tissue refinement where it enhances the skin's ability to decongest and clear while also evening out skin tone, for a smooth complexion. (facenearth.com)
Works1
- Niacinamide works best when used in leave-on skincare formulas such as serums and moisturizers. (biossance.com)
Safe5
- Niacinamide is likely safe when used appropriately. (medlineplus.gov)
- Niacinamide is possibly safe when taken in doses up to 900-1500 mg daily. (medlineplus.gov)
- Niacinamide is possibly safe. (medlineplus.gov)
- Niacinamide is likely safe when taken in recommended amounts. (medlineplus.gov)
- Niacinamide is safe for all skin types, including sensitive skin. (biossance.com)
Increase2
- Niacinamide might increase blood sugar. (medlineplus.gov)
- Taking niacinamide seems to increase the risk of low platelet levels in people with kidney failure who are on dialysis. (medlineplus.gov)
Improve1
- Taking niacinamide by mouth seems to improve joint flexibility and reduce pain and swelling in people with osteoarthritis. (medlineplus.gov)
Option1
- A really affordable niacinamide option. (drlauraclinic.ie)
Helpful1
- There is interest in using niacinamide for a number of other purposes, but there isn't enough reliable information to say whether it might be helpful. (medlineplus.gov)